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We describe a non-invasive approach for recovering RNA from the surface of skin via a simple tape stripping
procedure that permits a direct quantitative and qualitative assessment of pathologic and physiologic biomarkers.
Using semi-quantitative RT-PCR we show that tape-harvested RNA is comparable in quality and utility to RNA
recovered by biopsy. It is likely that tape-harvested RNA is derived from epidermal cells residing close to the
surface and includes adnexal structures and present data showing that tape and biopsy likely recover different cell
populations. We report the successful ampliﬁcation of tape-harvested RNA for hybridization to DNA microarrays.
These experiments showed no signiﬁcant gene expression level differences between replicate sites on a subject
and minimal differences between a male and female subject. We also compared the array generated RNA proﬁles
between normal and 24 h 1% SLS-occluded skin and observed that SLS treatment resulted in statistically
signiﬁcant changes in the expression levels of more than 1,700 genes. These data establish the utility of tape
harvesting as a non-invasive method for capturing RNA from human skin and support the hypothesis that tape
harvesting is an efﬁcient method for sampling the epidermis and identifying select differentially regulated
epidermal biomarkers.
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Contact dermatitis, a common skin reaction, involves
several signaling pathways. Irritant contact dermatitis
(ICD) predominantly involves keratinocyte activation (Freed-
berg et al, 2001), whereas Langerhans’ cell presentation of
antigen to Tcells in draining lymph nodes and recognition of
the offending allergen in skin by memory T cells control the
initiation and expression of allergic contact dermatitis (ACD;
Feghali and Wright, 1997) Clinically, both contact dermati-
tides are characterized by pruritus, erythema, and edema.
This commonality of the clinical signs and symptoms makes
distinguishing between ICD and ACD difficult at the clinical
level, particularly when symptoms are subtle. By contrast,
at the molecular level, ICD and ACD are believed to be
characterized by unique mRNA patterns, although the
published literature is conflicting (Hoefakker et al, 1995;
Flier et al, 1999; Morhenn et al, 1999; Ryan and Gerberick,
1999; Ulfgren et al, 2000; Cumberbatch et al, 2002).
Documentation of simple and complex mRNA profiles is
possible using RT-PCR and DNA microarray technologies.
Using the technique of tape stripping, RNA can be
harvested from both normal and inflamed skin (Morhenn
et al, 1999) and by combining tape stripping and RNA
profiling, it may be possible to non-invasively establish a
diagnosis of ICD or ACD.
In this study, we expand upon the work of Morhenn et al
(1999) who used adhesive tape as a substitute for punch
biopsy to non-invasively sample the epidermis. Morhenn
et al demonstrated that when a skin site was tape stripped
20 or more times, it was possible to recover sufficient RNA
from skin cells adherent to the tapes to detect and semi-
quantify specific mRNAs using the ribonuclease protection
assay. We demonstrate in this work that sufficient RNA can
be recovered using sequential application of as few as four
small tapes.
In order to document the use of tape harvesting as an
accurate and reliable sampling method we performed a
clinical trial in which occlusive patches containing either 1%
SLS (irritant) or water (vehicle control) were applied to the
mid-back of 10 subjects for 24 h. The sites were then
clinically assessed and, along with normal control skin,
surface cells were harvested with four applications of
individual tapes and by shave biopsy. RNA was extracted
from the tapes and biopsies and assayed semi-quantita-
tively for Il-1b, IL-8, GAPDH, and b-actin mRNA using
fluorescent, quantitative RT-PCR. The results showed
consistent increases in IL-1b and IL-8 mRNA in inflamed
skin relative to untreated skin. We further report the
successful use of tape-harvested RNA to profile normal
Abbreviation: PPDE, posterior probability of differential expression;
SLS, sodium lauryl sulfate
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and experimentally inflamed skin using DNA microarrays.
This profile of SLS-irritated skin is the first step in the
definition of RNA profiles designed to differentiate irritant
from allergic skin reactions.
Results
Total RNA yields RNA was recovered from 27 of 30 skin
sites using four tapes as described in Materials and
Methods. The amount of total RNA recovered was variable
from site to site and subject to subject (data not shown).
The average mass of RNA recovered from normal skin sites
was 0.92 ng (  0.35) with a range of 0 (two samples)–3.2
ng. The average mass of RNA recovered from water-
occluded skin was 0.69 ng (  0.27) with a range of 0 (one
sample)–2.7 ng. SLS inflamed skin produced the greatest
average yield of RNA with an average of 185 ng (  76) and
a range of 0.067–747 ng.
Relative levels of housekeeping genes in tape-strip
samples and biopsies We have chosen as markers of the
inflammatory process IL-1b and IL-8 mRNAs. We have
accounted for differential recovery of total RNA mass in a
sample by normalizing these mRNAs to an internal control,
the b-actin transcript. We then calibrated this normalized
RNA ratio to the analogous ratio in a control sample (normal
skin) using the comparative or DDCt method (described in
Materials and Methods). In this study, IL-1b and IL-8 mRNA
are predicted to increase relative to b-actin in response to
SLS treatment, whereas the level of housekeeping mRNAs,
such as b-actin and GAPDH are assumed to remain
constant. We have tested the assumption that house-
keeping mRNAs such as GAPDH and b-actin are unchang-
ing among different samples by measuring the relative ratio
of these two mRNAs.
If the relative ratio of two housekeeping genes is
unchanged in different samples, the relative ratio of
GAPDH/b-actin mRNA between two samples should be
equal to 1. The data in Table I reveal the fold-change of the
GAPDH/b-actin mRNA ratio in SLS- and water-treated
samples relative to normal skin and also water-treated skin.
The tape sample data show that the average fold-change in
SLS samples was 0.55, whereas the average fold-change in
water-treated samples was 1.14. Biopsy samples showed
similar and minor changes with SLS-treated samples having
an average 0.39 fold-change, whereas water-treated sam-
ples have an average 0.53 fold-change. Individual subject
data are shown in Online Table S1. Although there are some
examples of statistically significant changes relative to the
normal skin, these changes are not sufficient to explain the
fold-changes in IL-1b and IL-8, which are reported in Table I.
Thus, it is likely that our housekeeping genes do change
relative levels in response to SLS and water treatment, but
the magnitude of those changes is minor. Similar observa-
tions and conclusions have been reported by Paludan and
Thestrup-Pedersen (1992) and Grangsjo et al (1996).
IL-1b/b-actin mRNA ratios in SLS-irritated and control
skin Data in Table I reveal the average fold-change of the
IL-1b/b-actin mRNA ratio in water-occluded and SLS-
occluded skin relative to normal skin, in tape- and biopsy-
harvested RNA samples. Individual subject data can be
found in Online Table S2. Table I shows that on average the
IL-1b/b-actin mRNA ratio in biopsy samples of SLS-treated
skin was elevated at least 11-fold (495% confidence
interval) compared with normal skin. Furthermore, the IL-
1b/actin ratio was 4.42-fold elevated in SLS- relative to
water-treated samples. In six of 10 subjects water occlusion
produced significant (495% confidence) increases in the
IL-1b/actin ratio but this increase was typically 2–4-fold and
was always smaller than the respective effect of SLS
occlusion (Online Table S3). Thus SLS-occlusion produced
the most consistent elevation of the IL-1b/actin mRNA ratio
but water-occlusion did effect a similar albeit smaller
response.
Table I. Summary of fold-change in GAPDH, IL-1b, and IL-8 mRNA relative to b-actin mRNA in SLS-treated and water-treated skin
calibrated to control skin
mRNA Calibratorb
Average fold-change by sampling method and treatmenta
Tape Biopsy
Water SLS Water SLS
GAPDH Normal 1.14 (0.6–2.14) 0.55 (0.31–0.99) 0.53 (0.43–0.66) 0.39 (0.29–0.53)
Water 1 0.48 (0.36–0.65) 1 0.74 (0.55–1)
IL-1b Normal ND 42.66 42.49 411
Water 1 41.5 1 4.42 (1.42–13.76)
IL-8 Normal 1.94 (0.63–5.99) 10.32 (3.89–27.34) 41.54 452.45
Water 1 5.31 (2–14.1) 1 34.06 (6.37–181.87)
aAverage fold-change in up to 10 subjects (n¼ 8 for normal skin tape samples, n¼ 9 for water-treated skin tape samples and n¼10 for all others). The
average fold-change is calculated from the subject-average DCt values given in Online Tables S3, S4, S7. Individual fold-change values are reported in
Online Tables S1, S2, S5. Values preceded by4 are lower limit estimates necessitated by the fact that the applicable mRNA was not detectable in the
control (calibration) samples. The 495% confidence interval for fold-change is given in parenthesis.
bSLS and water samples are calibrated to normal skin samples; additionally, SLS samples are calibrated to the water sample. Calibration is described
in Materials and Methods.
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Data in Table I also reveal the fold-change of IL-1b/b-
actin mRNA in tape-harvested samples of water-occluded
and SLS-occluded skin relative to water-occluded and
normal skin. Individual subject data are shown in Online
Tables S2 and S3. In most subjects, IL-1b was undetectable
in normal and water-treated, tape-harvested skin samples.
The average fold-change of the IL-1b/actin ratio was
estimated to be at least 2.66-fold in SLS-treated samples.
Although the average fold-change for eight subjects was
modest, five of these subjects showed significant (495%
confidence) IL-1b/actin ratio increases that were in qualita-
tive agreement with the biopsy data (Online Table S3).
Analysis of the remaining five samples was indeterminate
because IL-1b mRNA was not detected in either the water
or normal skin sample.
IL-8/b-actin mRNA ratios in SLS-irritated and control
skin Table I reveals the fold-change of the IL-8/b-actin
mRNA ratio in water-occluded and SLS-occluded skin
relative to normal skin. The data demonstrate that the IL-
8/actin ratio was on average 52-fold elevated in SLS-treated
skin samples relative to normal skin and 34-fold elevated
relative to water-treated skin. Biopsy samples from nine of
10 untreated skin sites had undetectable IL-8 mRNA levels
and the sole normal skin biopsy sample with detectable IL-8
mRNA was close to the level of detection (Online Tables S4
and S5). Thus IL-8 mRNA was generally not detectable in a
biopsy of normal skin.
Table I reveals that the IL-8/actin mRNA ratio was on
average 10-fold increased in tape-harvested samples from
SLS-occluded sites (495% confidence interval) and 1.94-
fold increased in water-treated samples (not significantly
different than normal skin). We conclude that the tape data
are in good qualitative agreement with the biopsy data, with
a majority of inflamed sites revealing increases in IL-8
mRNA.
During our analysis of IL-8 mRNA in biopsy and tape
samples, we observed that although the fold-change was in
qualitative agreement between the two methods, the
primary DCt data were strikingly different (Online Table
S4). As described in Materials and Methods, DCt is a
measure of the ratio of two mRNAs in a sample. Online
Table S4 shows that the DCt, IL-8 for tape samples is very
different than that of biopsy samples—for both SLS- and
water-treated skin sites—and this difference is highly
significant (both p-values o0.005). The most striking
example of this is revealed by a comparison of the average
DCt, IL-8 in tape-harvested samples compared with biopsy-
harvested samples of water-occluded sites. For tape-
harvested samples the average (DCt, IL-8)water is 1.54,
whereas for biopsy samples it is 9.22 (Online Table S4).
The data suggest that in the cell population harvested by
tape, IL-8 mRNA is much more abundant relative to b-actin
mRNA than in biopsy samples. The average relative
abundance can be estimated as equal to 2(1.54–9.22) or
205. In this calculation, the biopsy sample acts as the
‘‘calibrator’’, thus the tape samples have, on average, a
205-fold greater IL-8/actin mRNA ratio than biopsies. A
similar calculation can be performed with the SLS sample
data (Online Table S4), which also reveals a highly sig-
nificant difference between tape and biopsy (DCt, IL-8)SLS
values (po0.005). We conclude from this data that tape
harvesting recovers a distinctly different cell population than
does biopsy.
DNA microarray analysis of RNA extracted from normal
skin using tape The success in the above analysis of tape-
harvested RNA from different skin sites suggested that this
RNA might be amenable to amplification and hybridization
to DNA microarrays. In order to assess the reproducibility
and consistency of tape-harvested RNA samples for gene
expression profiling experiments, we collected three sam-
ples from the upper back of each of two healthy individuals,
one male (sample C1, C2, and C3) and one female (sample
A5, A6, and A9). Approximately 1 ng of total RNA was
isolated and the mRNA was amplified and biotin labeled
using a MessageAmp aRNA kit (Ambion Inc., Austin, Texas)
as described in Materials and Methods. The resulting biotin-
labeled aRNA from each sample was used for hybridization
to an Affymetrix HG-U133A GeneChip.
The results in Table II show the differences observed
when a matrix of pairwise gene expression comparisons
between two GeneChips was performed using Affymetrix
Microarray Suite software. These data show an average of
only 12% variance among gene measurements, regardless
of whether data from different sites on the same individual
or sites from different individuals are compared. Further-
more, comparing the data in quadrant three of Table II (A
versus C) to the data in quadrants one (A versus A) and four
(C versus C) shows that about 15% of this variance is due to
either gender difference (A versus C) or inter-subject
variation (A versus A or C versus C). Thus, amazingly little
variance is contributed by samples obtained from different
sites or from different individuals.
To compare these data in a more quantitative manner,
the three Affymetrix GeneChips each hybridized with targets
from RNA samples obtained from individual A were
compared with three GeneChips hybridized with targets
from the three RNA samples obtained from individual C.
These data were analyzed with a regularized t test (Long
et al, 2001) implemented in the Cyber-T statistical program.
This three-by-three comparison revealed 21,790 probe sets
Table II. Percentage of the measurement of gene expression
reported as unchanged by the Affymetrix MAS 5.0 software for
each of all possible pairwise comparisons among GeneChips
(A5, A6, A9, C1, C2, and C3) hybridized with aRNA obtained
from three different locations on the upper back of two
subjects (A and C)
GeneChip/subject ID (%)
A5 A6 A9 C1 C2 C3
A5 100
A6 88.90 100
A9 90.80 86.10 100
C1 89.80 88.20 87.40 100
C2 85.00 85.30 83.10 89.60 100
C3 88.00 88.00 87.30 88.90 83.70 100
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that exhibited gene expression levels above background for
all three sites from each subject. Of these genes 1117 (5%)
were differentially expressed with p-value less than 0.0035,
which based on the global false positive and negative levels
of this dataset corresponds to a PPDE value of 0.95. Thus,
56 of the 1117 differentially expressed genes that exceed
this p-value threshold are expected to be false positives.
The source of these inter-subject gene expression differ-
ences remains to be determined; however, at least one of
these differences is gender based. For example, the gene
with the smallest p-value and the highest PPDE value is the
Y-linked ribosomal protein S4 (PRS4Y). It is likely that
differences that are not gender based are a reflection of
normal variation of gene expression between individuals.
These data are available at www.igb.uci.edu.
DNA microarray analysis of normal versus water-
occluded and SLS-occluded skin In a separate experi-
ment, a total of nine RNA samples ranging from 1 to 10 ng
were isolated by tape harvesting from three untreated, three
water-occluded, and three SLS-occluded sites of each of
three individuals. mRNA from each of the nine samples was
amplified, biotin labeled and used for hybridization to each
of nine Affymetrix HG-U133A GeneChips as shown in Fig 1.
Untreated versus SLS-treated samples A comparison of
gene expression levels between three untreated (A1, B1,
C1) samples and three SLS-treated (A2, B2, C2) samples
revealed 21,031 genes that exhibited expression levels
above background for all samples. To assess the con-
fidence in global changes in gene expression, methods
implemented in Cyber-T were used to determine the
posterior PPDE of each gene based on experiment-wide
global false positive and negative gene measurement levels
as described by Hung et al (2002) and Baldi and Hatfield
(2002). When untreated versus SLS-occluded data are
compared, the p-values for the differentially expressed
genes are low and cluster toward 0. This is consistent with
highly statistically significant differences among measure-
ment levels of some genes. In fact 1771 genes are
differentially expressed with a threshold of p¼ 0.003, which
corresponds to an experiment-wide probability for differ-
ential expression (PPDE value) equal to or greater than 0.99.
These data are available at www.igb.uci.edu.
SLS- versus water-treated samples A comparison of gene
expression levels between three SLS-treated (A2, B2, C2)
samples and three water-treated (A3, B3, C3) samples
revealed 21,307 genes that exhibited expression levels
above background for all samples. Based on a threshold of
p¼0.003, 1364 genes are differentially expressed with a
PPDE value of 0.99. Of these, 1063 genes are also
differentially expressed with a p-value of 0.003 and a PPDE
value of 0.99 when SLS and untreated samples are
compared. These data are available at www.igb.uci.edu.
Untreated versus water-treated samples A comparison of
gene expression levels between three untreated (A1, B1,
C1) samples and three water-treated (A3, B3, C3) samples
revealed 21,164 genes that exhibited expression levels
above background for all samples. This comparison
revealed no statistically significant differential expression.
Nevertheless, based on our review of the genes assigned
the lowest p-values, many of which are associated with
inflammation, we believe that the water treatment does lead
to some changes in gene expression compared with
untreated control skin. These data are available at www.
igb.uci.edu.
For purposes of discussion, only the 100 genes dif-
ferentially expressed with p-values less than 1.4  1010
and PPDE values greater than 0.99 are discussed here, in
Fig 2 and are fully described in Online Table S6. An
examination of these top 100 genes most significantly
altered when the SLS-treated skin samples were compared
with untreated skin samples revealed that, as expected,
most of these genes carry out functions related to tissue
inflammation and injury (Fig 2; Online Table S6). These
differentially expressed genes are proteinases, protease
inhibitors, cytokines, chemokines, complement compo-
nents, HLA factors, or receptors involved in immune
regulation. These associations with inflammation and injury
responses for many of these mostly upregulated genes are
documented in the literature (Online Table S6). These results
demonstrate that the tape-stripping method described here
harvests RNA suitable for complete gene expression pro-
files of the skin that accurately reflect its pathological state.
Discussion
Recent advances in molecular medicine have made the
possibility of molecular diagnosis a reality (Aitman, 2001;
Bertucci et al, 2001; Galiegue and Casellas, 2002; Lacroix
et al, 2002; Whipple and Kuo, 2002; Satagopan and
Figure1
Experimental design of SLS irritation protocol. Details are described
in the text.
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Panageas, 2003). Through the use of microarrays and RNA
profiling it is becoming increasingly clear that simple and
complex cell populations can be monitored or ‘‘profiled’’
with the intent of understanding the physiologic state of
those cells or tissues. This information is expected to lead
to more accurate and possibly predictive diagnoses. We
have shown here that the use of four small tape strips is an
effective and basically non-invasive approach to capturing
messenger RNA from the surface of skin and that this
technique permits a direct quantitative and qualitative
assessment of pathologic and physiologic biomarkers as
a function of normal physiology.
We have assayed semi-quantitatively the levels of IL-1b
and IL-8 mRNA relative to b-actin in normal, water and SLS-
occluded skin sites and shown that RNA from tape and
biopsy samples produce qualitatively similar results. In
order to account for the possibility that changes in b-actin
mRNA were responsible for observed changes in the
interleukin/b-actin mRNA ratios (Suzuki et al, 2000; Bustin,
2002; Tricarico et al, 2002) we quantified the levels of two
housekeeping genes relative to each other. The resulting
data (Table I) showed that although the GAPDH/b-actin
mRNA ratio is different in differently treated skin samples,
the magnitude of this difference is not capable of explaining
the observed changes in IL-1b and IL-8 mRNA levels
induced by SLS treatment. This fact is most clearly
demonstrated by tape-harvest and biopsy data in which
IL-1b and IL-8 mRNA are virtually undetectable in control
samples but easily detected in SLS-treated samples, an
observation that cannot be explained by minor changes in
b-actin mRNA levels. In addition, IL-1b and IL-8 mRNAs and
proteins have been well characterized in inflammation
and are known to become elevated in response to SLS and
other treatments (Paludan and Thestrup-Pedersen, 1992;
Grangsjo et al, 1996; Corsini and Galli, 1998; Tomic-Canic
et al, 1998; Freedberg et al, 2001; Perkins et al, 2001;
Cumberbatch et al, 2002; Coquette et al, 2003). Thus our
data, from both tape and biopsy, are consistent with
published observations.
Biopsy and tape harvesting are not equivalent sampling
methods, and therefore, should not be expected to yield
identical results. Tape harvest is restricted to the skin
surface, and therefore, may preferentially recover vellus hair
follicles and cells lining sebaceous, eccrine and sweat ducts
as well as corneocytes (not predicted to contain RNA). Our
method of using a single application of four individual tapes
does not result in glistening of normal skin and thus does
not bare the viable epidermis. In contrast, a shave biopsy is
expected to include not only cells of the epidermis (primarily
keratinocytes, melanocytes, and immune cells) but fibro-
blasts from the upper dermis. The potential enrichment of
surface epidermis and adnexal structures conveyed by
our circular tape compared with a shave biopsy can be
appreciated by considering that the surface area of a tape is
284 mm2, whereas the surface area of a 2  2 mm shave
biopsy is 4 mm2.
The hypothesis that tape and biopsy recover different cell
populations is supported by the DCt, IL-8 data previously
discussed and presented in Online Table S4. Similarly,
supportive data are presented in Online Table S7 for
DCt,GAPDH values. Thus we propose that tape-harvested
cells represent an enrichment of a subpopulation of cells
found in a shave biopsy. This data imply that some
differentially expressed biomarkers may be best detected
in tape rather than biopsy-harvested epidermal samples.
Identification of biomarkers diagnostic of clinical irritation
has been a long sought goal (Muller-Decker et al, 1994;
Boelsma et al, 1998; Muller-Decker et al, 1998; van Ruissen
et al, 1998; Komine et al, 2001; Perkins et al, 2001; Boxman
et al, 2002; Perkins et al, 2002; Coquette et al, 2003). We
have used changes in IL-1b and IL-8 mRNA as indicators of
irritation and shown that most but not all irritated sites
display increased levels of these normalized mRNA markers
(Table I and Online Tables S2 and S5). Our data also show
that tape-harvested and biopsy-recovered RNA are qualita-
tively equal in their ability to reveal an irritant skin reaction.
With respect to biopsy samples, it is evident that neither
marker is 100% efficient at diagnosing irritation, a result
observed for every biomarker proposed to be diagnostic of
erythema and inflammation (Grangsjo et al, 1996; Muller-
Decker et al, 1998; Chung et al, 2001; Perkins et al, 2001;
Boxman et al, 2002). The current limitation of the tape-
harvest assay is the inefficiency in detecting certain markers
in samples with limiting amounts of RNA, a subject
discussed below. But in comparison with the Sebutape
assay (immunoassay of IL-8 protein; Perkins et al, 2001) for
irritation, which has a sensitivity (Hoffrage et al, 2000) of
approximately 30%, mRNA biomarkers seem to possess
superior potential. Our observation that water occlusion
produced increases of our biomarker ratios in some
subjects has been reported by others (Grangsjo et al,
1996; Howie et al, 1996; Perkins et al, 2001).
It is reasonable to assume from the data presented here
and in the literature that singular or limited multiplex assays
will not be sufficiently predictive or diagnostic of irritation.
Since our results show that the tape-stripping method
Figure 2
Functional grouping of the top 100 differentially expressed genes
between untreated and SLS-treated skin with p–values less than
1.4  1010 and PPDE values greater than 0.99. Genes that are
upregulated in SLS-treated conditions are represented with dark gray
color and genes that are downregulated in SLS-treated conditions are
represented by light gray. The number in parentheses is the number of
genes in each functional group that has been previously documented to
be related to the inflammatory response.
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harvests RNA suitable for DNA microarray experiments, and
that these gene expression profiles reflect the pathological
state of human skin, however, it should be possible to identify
a subset of genes whose differential expression patterns can
be correlated with different pathological states with a high
degree of statistical accuracy. The fact that 1700 differentially
expressed genes have been identified with high statistical
confidence sets the stage for the creation of small custom
DNA arrays designed to identify patterns of gene expression
diagnostic of irritant skin reactions, possibly diagnostic of
different irritants and predictive of irritant or toxic reactions.
The next step along this path is to identify the analogous set
of genes expressed during an allergic skin response, identify
genes unique to the irritant or allergic response and combine
them into one DNA array, which could be used to determine if
a mild reaction to a substance is irritant or allergic in nature.
Such an array could also be used to test a variety of irritants
and allergens for unique profiles.
Analysis of the top 100 genes differentially expressed in
our SLS-treated samples shows that well over half of these
genes have been implicated in injury and inflammation
(Fig 2; Online Table S6), with most of these genes being
upregulated. The DNA array data also confirm our RT-PCR
data with IL-1b being found in the top 100 most significantly
differentially expressed (p-value less than 3.56  1011,
probability of differential expression (PPDE) value 40.99)
genes. Although the IL-8 gene was not among the top 100
most significantly differentially expressed genes, it was
ranked number 395 in the normal versus SLS-treated
comparisons (p-value¼6  108, PPDE¼ 0.99) and ranked
number 183 (p-value¼ 5  108, PPDE¼0.99) in the SLS-
treated versus water-treated comparisons. The expression
level of IL-1b was elevated 11-fold and IL-8 was elevated 8-
fold in the SLS-treated sample. Interestingly, many of the
downregulated genes are hair keratins and keratin asso-
ciated proteins selectively expressed in the hair during the
anagen phase of the hair cycle. Either, the occlusive SLS
treatment removes hair prior to the tape stripping or the
treatment blocks anagen in the hair follicles.
We have shown that RNA can be non-invasively and
productively recovered from the surface of the skin using four
small tape strips. The number of tape strips can be reduced
to two in conditions where the surface of the skin has been
disrupted, such as SLS occlusion for 24 h (Nicholas Benson,
personal communication). Furthermore, the limitation of
capturing small amounts of RNA from some skin sites can
be effectively overcome by obtaining replicate control
samples (data not shown) and by the appropriate choice of
mRNA biomarker (discussed below). We have also presented
data that the DCt, IL-8 value, which is normally used to
calculate a DDCt value (calibrated fold-change), has revealed
that tape and biopsy recover different cell populations.
In this study, the quantity of RNA recovered from different
individuals and skin sites was variable, with significantly
more RNA being recovered from SLS-treated sites than
normal skin sites. The large amount of RNA recovered from
the SLS-irritated sites is consistent with the known effects
of SLS, which effects invasion of inflammatory cells and
creates a weakened barrier facilitating the removal of the
inflamed epidermis. We have since shown that recovery of
RNA from normal skin is also a function of anatomical site
and similar sites vary between individuals with respect to
RNA yield (data not shown).
Although the variability of total RNA recovered does not
affect the results of relative gene quantitation, the recovery
of very small amounts of RNA did affect our ability to fully
analyze some samples. In this respect, the choice of
biomarkers may be as important as the amount of RNA
recovered from a site. For instance, Online Table S7 shows
that most tape-harvested samples could be assayed for
b-actin and GAPDH mRNAs and thus calibrated GAPDH/
actin ratios could be calculated (Online Table SI). Online
Tables S2 and S5 reveal, however, that some of these same
samples do not have calibrated IL-1b/actin or IL-8/actin
mRNA ratios, with the IL-1b assay being the most affected.
The reason for this difference between biomarker assays
lies in the relative abundance of the specific mRNA.
Because GAPDH mRNA is approximately equal in abun-
dance to b-actin mRNA, all samples with detectable actin
mRNA were successfully assayed for GAPDH. Likewise, we
were highly successful at calibrating IL-8/actin mRNA ratios
in water and SLS treated tape-harvested skin samples
because IL-8 message is relatively abundant in these
samples. Thus the biomarker mRNA that is the most
abundant relative to the normalizing mRNA will make the
most efficient use of RNA mass. Therefore, candidate
biomarker mRNAs should be chosen for best sensitivity,
positive predictive value and high relative abundance when
RT-PCR is to be used for detection and tape harvesting is to
be the sampling method.
We have chosen to demonstrate the utility of tape-
harvested RNA for semi-quantitative RT-PCR and micro-
array applications for several reasons. Both methods have
particular advantages and are appropriate in different
circumstances. The use of microarrays is an invaluable tool
for the discovery of diagnostic and prognostic biomarker
candidates and may be essential for subcategorizing
disease states, which may demand simultaneous assay of
hundreds of biomarkers. The use of microarrays, however,
is expensive and technically laborious. Quantitative RT-PCR
is less expensive and less technically demanding and is
appropriate for studies where a limited number of known
markers are being studied.
In summary, our data show that the tape-stripping
method non-invasively collects skin samples from normal
and inflamed skin that are suitable for RNA isolation and
gene expression profiling experiments. In the future, this
method can be used to profile expression of a large number
of genes in different skin conditions with the goal of
designing custom arrays that allow molecular diagnoses
of skin disorders.
Materials and Methods
Clinical protocols The study protocols were reviewed and
approved by an independent IRB (BioMed IRB, San Diego,
California), all subjects signed informed consent and protocols
adhered to the Declaration of Helsinki Guidelines. Ten healthy
women, ages 21–55 were enrolled in the study. Regions of
unblemished, normal appearing skin on the mid-back were chosen
for the application of two occlusive patches in the form of
bandages approximately 4 cm  6.5 cm. The bandages were
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made using a clear, non-porous plastic hypoallergenic adhesive
tape. In the center of this tape was a Webril (non-woven cotton)
patch measuring approximately 2 cm  4.5 cm. One Webril patch
contained 0.6 mL of 1% aqueous sodium lauryl sulfate and the
other contained 0.6 mL of sterile water as the vehicle control.
Patches were arranged such that the SLS patch was superior and
directly adjacent to the water patch; the area of normal control skin
was inferior to and adjacent to the water patch. At 24 h post
application, the SLS and water patches were removed and the skin
allowed to air dry for 15 min before scoring. The sites were scored
by a trained technician using the scale provided below. Patched
sites were large enough that two areas could be tape harvested
without overlap and room left for a shave biopsy (  2  2 mm).
Skin sites were tape stripped with four tapes each; shave biopsies
were taken under local anesthetic (lidocaine HCl 1% and epinephr-
ine 1:100,000; Abbott Laboratories, Abbott Port, Illinois). An area of
normal skin was similarly tape harvested and shave biopsied. Tapes
were stored in individual eppendorf tubes at –80 until extraction;
biopsy samples were placed in buffer RLT and stored at –80 until
extraction. Skin responses to each patch application were examined
and graded under light supplied by a 100-W incandescent blue bulb.
The following grading scale was used: 0, no visible reaction; 1, slight,
pink, patchy erythema; 2, mild confluent, pink erythema; 3, moderate
erythema (definite redness) with edema; 4, strong erythema (very
intense redness) with edema. In a second study, three subjects had
three patches containing 1% SLS and three water patches applied
to the mid-back for 24 h. Patches were removed, scored and tape
stripped as above. In a third study, two individuals were tape
stripped on normal skin on the upper back at three adjacent sites as
above. RNA harvested in these last two studies was used in the DNA
microarray experiments described below.
Materials and reagents Adhesive tape was purchased from
Adhesives Research (Glen Rock, Pennsylvania) in bulk rolls. These
rolls were custom fabricated into small circular discs, 17 mm in
diameter, by Diagnostic Laminations Engineering (Oceanside,
California). Total spleen RNA was purchased from Ambion.
‘‘RNeasy’’ RNA extraction kit and Sensiscript Reverse Transcrip-
tase kit were purchased from Qiagen (Valencia, California). PCR
primers and probes (TaqMan Pre-Developed Assay Reagents) and
TaqMan Universal Master Mix, which included all buffers and
enzymes necessary for the amplification and fluorescent detection
of specific cDNAs, were purchased from Applied Biosystems
(Foster City, California). Total mRNA was amplified using the
MessageAmp aRNA kit purchased from Ambion Inc. (Austin,
Texas). Human Genome U133A DNA chips were purchased from
Affymetrix Inc. (Santa Clara, California).
Isolation of RNA The RNA within skin cells adherent to the four
tapes used to harvest a site was pooled by simultaneously
extracting the tapes in a volume of buffer RLT (supplied with
RNeasy kit). Extraction was performed using the manufacturer’s
directions and included a Proteinase K digestion, sonication of
tapes and ‘‘on-column’’ DNase I digestion. RNA was eluted in 100
mm of sterile, RNase-free water. Extraction of biopsies was
performed with the same kit according to the manufacturer’s
instructions.
Quantitative RT-PCR Ten mL of RNA was reverse transcribed (RT)
into cDNA with the Sensiscript Reverse Transcriptase kit and
random hexamers in a final volume of 20 mL according to the
manufacturer’s directions. The reaction was diluted 5-fold with
sterile, nuclease-free water (Ambion) for use in the subsequent
amplification/detection reaction. For each specific mRNA detec-
tion, three replicate RTþ reactions and one RT– (no RT; negative
control) reaction were performed. Two amplification/detection
reactions were done on each RTþ reaction to yield a total of six
independent determinations of the threshold value (Ct; discussed
below). All RT– reactions were amplified using two replicates and
were negative (data not shown).
Quantitation of RNA mass recovered with adhesive tape and
biopsy The amount of RNA recovered by tape is too small (in most
samples) to detect by UV. We have also found that contaminants in
the adhesive co-purify with the RNA and interfere with UV and
fluorometric detection. We therefore estimated the RNA mass
recovered from tapes by using quantitative RT-PCR with reference
to a standard curve (Ct, actin versus log[RNA]; Applied Biosystems,
2001) created from commercially purchased human spleen total
RNA. Spleen RNA was treated with DNase I and purified with the
Qiagen RNeasy kit following the manufacturer’s instructions.
Purified standard RNA was quantified spectroscopically using
O.D. 260. The standard curve was constructed using four
concentrations of RNA from 0.01 to 1 mg per mL. Each RNA
standard was reverse transcribed in triplicate and each RT reaction
amplified once to yield three replicates per standard concentration.
Amplification and detection of unknowns was accomplished as
described below using b-actin mRNA as the quantified marker.
Experimental samples were reverse transcribed in triplicate and
each RT reaction amplified in duplicate to yield a total of six
replicates. The average Ct, actin of these six replicates was used to
calculate the concentration of RNA in the unknown with reference
to the standard curve. The accuracy of this method relies on the
relative amount of b-actin mRNA to total RNA in the epidermis
being similar to that in human spleen. If the relative amount of b-
actin mRNA to total RNA is different between the two tissues then
our mass data will be similarly affected. Therefore, we describe all
tape-harvested RNA mass calculations as estimates to reflect this
uncertainty. RNA recovered from biopsies was quantified fluor-
ometrically with the RiboGreen RNA Quantitation Reagent (Mole-
cular Probes, Eugene, Oregon).
Ampliﬁcation and detection of speciﬁc mRNA Specific mRNAs
were converted to cDNA as described above. Specific cDNAs
were semi-quantified using gene-specific primer/probes (50-nucle-
ase assay) and fluorescence detection. Amplification and detection
assays were performed using TaqMan Pre-Developed Assay
Reagents (PDAR; Applied Biosystems) on an Applied Biosystems
7000 Sequence Detection System. IL-1b mRNA was semi-
quantitated relative to b-actin in a multiplex assay where b-actin
and IL-1b mRNA were detected simultaneously in the same tube.
Similarly, IL-8 was semi-quantitated by multiplex PCR with b-actin.
The data from these experiments are summarized in Table I and
individual subject data are reported in Online Tables S1–S5 and S7.
All data were confirmed by singleplex PCR assays where IL-8, IL-
1b and b-actin were separately assayed in individual tubes (data
not shown). GAPDH was semi-quantitated relative to b-actin using
a singleplex format. Thermal cycling conditions were: prior to
cycling, 2 min at 501C, then 10 min at 951C; then 40 cycles at 951C
for 15 s and 601C for 60 s. Threshold detection was set at 0.2 for all
assays.
Semi-quantitation of mRNA using the DDCt method and
calculation of fold-increase relative to a control sample In this
work, we use the comparative or DDCt method of calculating
relative gene expression levels between two samples. In the DDCt
method the levels of IL-1b, IL-8, and GAPDH mRNAs are assayed
quantitatively and normalized to b-actin mRNA to create a ratio of
the RNA of interest (i.e., IL-1b, IL-8, GAPDH) to b-actin mRNA for
each RNA sample. This ratio is then further normalized to a control
sample (‘‘calibration’’; Applied Biosystems, 2001). This relative
level of the RNA of interest to b-actin in a sample is given by the
equation k2(DCt) where ‘‘k’’ is an unknown constant related to the
PCR conditions and the fluorescent probe; because k is unknown,
the absolute ratio in a sample is also unknown. DCt is equal to the
difference between the experimentally derived Ct values for the
mRNA of interest and b-actin mRNA (for instance, DCt,GAPDH¼
Ct,GAPDH–Ct,actin for GAPDH normalized to actin). Although an
absolute mRNA ratio cannot be determined for a sample with only
Ct data, the relative ratio between two samples can be determined.
This is illustrated below using, as an example, GAPDH as the
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mRNA of interest, b-actin mRNA as the normalizing marker and
calibration of the SLS sample to the normal skin sample. The ratio
of GAPDH to actin mRNA in an SLS-treated sample is given by
mRNAGAPDH
mRNAbactin
 
SLS
¼ k2DCt;SLS ¼ k2ðCt;GAPDHCt;actinÞSLS ð1Þ
Likewise the ratio of GAPDH mRNA to actin mRNA in the normal
(control) skin sample is given by
mRNAGAPDH
mRNAbactin
 
normal
¼ k2DCt;normal ¼ k2-ðCt;GAPDHCt;actinÞnormal ð2Þ
By division of the first equation by the second, simplification, and
realization that under identical PCR conditions the constants k are
equal, it can be shown that
mRNAGAPDH
mRNAactin
 
SLS
,
mRNAGAPDH
mRNAactin
 
normal
¼ 2DDCt;SLS ð3Þ
where DDCt;SLS ¼ DCt;SLS  DCt;normal and DCt’s are defined above.
The Ct values are the experimentally determined number of PCR
cycles required to achieve a threshold fluorescence (statistically
significant increase in fluorescence over background) for the RNA
of interest and b-actin mRNA (Gibson et al, 1996; Heid et al, 1996).
Key to the comparative method and accuracy of Equation (3) is
the amplification efficiency of the mRNA being quantified. The
efficiency of PCR must be very similar if not identical for the
amplicons being assayed. In order to reassure ourselves that this is
true in this study we initially tested all the primer/probe sets at four
different spleen RNA concentrations. In a plot of Ct versus log[RNA
mass] the slope of the line is a function of the efficiency of
amplification (Applied Biosystems, 2001). In these experiments,
the slopes were essentially identical and Equation (3) accurately
portrays the relative ratios of our mRNAs (data not shown).
RT-PCR data analysis Experimental data are reported as the
number of cycles (Ct) required to achieve a threshold fluorescence.
Each reported Ct is the mean of six replicate measurements.
Calibrated fold-change calculations are made using Equation (3). A
calibrated mRNA ratio is considered to be significantly different
(495% confidence interval) than the control if the two standard
deviation range of fold-change does not include the value of 1,
which is the defined value of the calibrator (DDCt for the calibrator
is equal to 0, with a consequent fold-change relative to itself equal
to 20). The significance of DCt values (Online Tables S3, S4, and S7)
was determined by applying a two-sided, paired t test. In some
normal skin samples, IL-8 or IL-1b mRNA is undetectable. In these
cases, we report an estimated lower limit of fold-change based on
a lower limit of detection (Ct¼ 37). It is our experience that the
practical limit of detection for real-time PCR is 37 cycles. When the
threshold number of PCR cycles (Ct) extends beyond 37, Ct values
become highly variable or fluorescence does not achieve a
threshold value. With such data, we assign a value of Ct¼ 37
and consider the mRNA undetectable. To illustrate a calculation of
the lower limit of fold-change at 495% confidence we use data
from subject 7. Subject 7’s tape sample of an SLS-treated site has
a (DCt, IL-8)SLS¼0.68  0.08. The control DCt¼ (Ct, IL-8–Ct,actin)normal
¼ (Ct, IL-8–29.8); because the IL-8 mRNA was undetectable we
assign it a value of 37, hence DCIL-8 in the control sample is 37–
29.8¼ 7.2 (  0.13), the value reported in Online Table S4. We
can now calculate the calibrated fold-change of IL-8 in the SLS
sample as 2(DDCt)¼ 2(0.68–7.2)¼ 236. The lower limit of the
495% confidence interval, however, is given as 2(DDCtþ 2SD)¼
2(7.88þ 2  0.16)¼ 189, the value reported in online Table S4 (0.16
is the error in DDCt ¼ ðð0:08Þ2 þ ð0:13Þ2Þ1=2).
T7 linear RNA ampliﬁcation mRNA was amplified and biotin
labeled using a MessageAmp aRNA kit purchased from Ambion
Inc. according to the manufacturer’s instructions. Typical yields of
aRNA obtained from two rounds of amplification ranged from 30 to
80 mg.
Hybridization of biotinylated mRNA targets to Affymetrix
GeneChips, staining, data acquisition and data analysis Hy-
bridization and staining were performed according to the manu-
facturer’s instructions; a detailed protocol is available at the
manufacturer’s website.
DNA microarray data analysis The DNA microarray data re-
ported here were globally normalized and background subtracted
with the Affymetrix MAS 5.0 software package and modeled with
the dChip program of Li and Wong (2001). Statistical analyses were
performed with the Cyber-T statistical program available on line at
www.igb.uci.edu. The posterior probabilities of differential expres-
sion (PPDE) values (ranging from 0 to 1) for each gene were based
on estimates of experiment-wide false positive and negative levels
calculated by Cyber-T according to the methods of Allison and
Gadbury (2002) as described by Hung et al (2002) and Baldi and
Hatfield (2002).
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